ENT and Allergy Associates is a prominent player in the health care industry, founded in 1998 and headquartered in the United States. With a strong emphasis on convenience and access, the company operates over 50 office locations across various counties and metropolitan areas, including Long Island, New York City, and northern New Jersey. Boasting a team of over 300 clinicians, the company offers a wide array of services, including General Adult and Pediatric ENT, Voice and Swallowing, Facial Plastics and Reconstructive Surgery, Disorders of the Inner Ear and Dizziness, Asthma, Clinical Immunology, Diagnostic Audiology, Hearing Aid dispensing, and Sleep and CT Services. ENT and Allergy Associates' commitment to state-of-the-art care for ear, nose, throat, and allergy disorders is reinforced by its utilization of the latest medical technology. Their ability to provide a comprehensive suite of services is further supported by the convenience of a large group practice, offering evening and weekend hours and prompt appointment scheduling. Though specific details regarding their last investment and associated investors are not available at present, the company's widespread presence and holistic approach to healthcare services position it as an attractive potential investment opportunity for venture capitalists seeking to tap into the ever-evolving health care market. With its established infrastructure and considerable reach, ENT and Allergy Associates presents an intriguing proposition for investors looking to capitalize on the demand for high-quality, accessible healthcare services.
There is no investment information
No recent news or press coverage available for ENT and Allergy Associates.